Enrique Conterno

(Mr. Enrique Conterno)

Currently holds a position at FibroGen Inc

Positions
Position Company Period
Chief Executive Officer, Director FibroGen Inc Jan. 6, 2020 -
Senior Vice President and President - Lilly Diabetes and President - Lilly USA Eli Lilly and Co Feb. 1, 2017 - Dec. 31, 2019
Senior Vice President and President - Lilly Diabetes Eli Lilly and Co Nov. 1, 2009 - Feb. 1, 2017
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-07-10 2023-07-07
US FibroGen Inc (FGEN)
S Sale
1,880 -0.5%
2.80
5,264 USD 		1,880 -0.5% 2.80 5,264 USD
2023-06-09 2023-06-07
US FibroGen Inc (FGEN)
S Sale
6,106 -1.6%
17.04
104,033 USD 		6,106 -1.6% 17.04 104,033 USD
2023-06-09 2023-06-07
US FibroGen Inc (FGEN)
PS Planned sale
2,791 -0.7%
17.04
47,550 USD 		2,791 -0.7% 17.04 47,550 USD
2023-04-11 2023-04-10
US FibroGen Inc (FGEN)
S Sale
1,869 -0.5%
19.52
36,483 USD 		1,869 -0.5% 19.52 36,483 USD
2020-06-12 2020-06-11
US FibroGen Inc (FGEN)
B Purchase
19,800 +247.5%
35.28
698,599 USD 		19,800 +247.5% 35.28 698,599 USD
2020-06-12 2020-06-10
US FibroGen Inc (FGEN)
B Purchase
8,000 +inf%
36.29
290,282 USD 		8,000 +inf% 36.29 290,282 USD
2019-02-20 2019-02-15
PS Planned sale
25,000 -15.8%
121.00
3,025,000 USD 		25,000 -15.8% 121.00 3,025,000 USD